Encephabol By Pharma Trade,
Pas encore membre de TradeKey.com? Inscrivez-vous pour vous connecter avec 9 millions d'importateurs et exportateurs.
Rejoignez-le maintenant c'est gratuit |
BOOK A CALL
Book Call On Your Favorite Time

By Signing Up. I agree to TradeKey.com Terms of Use, Privacy Policy, IPR and receive emails related to our services

Contact Us
product
Prev
Encephabol
Next

Encephabol

46 ~ 54 / Box

|

5 Box Minimum Order

Pays:

Ukraine

N ° de modèle:

Encephabol

Prix FOB:

46 ~ 54 / Box Obtenir le dernier prix

Localité:

Donetsk

Prix de commande minimale:

46 per Box

Commande minimale:

5 Box

Packaging Detail:

package must not exceed 2kg

Heure de livraison:

2 weeks by post or 2-5 days by EMS/DHL

Capacité de Fournir:

50 Box per Day

Payment Type:

D/P, Western Union, Money Gram

Groupe de produits :

Contacter maintenant

Pharma Trade

Ukraine

Membre gratuit

Personne à contacter Mr. Yuriy

17/91 Leninskiy ave., Donetsk, Donetsk

Contacter maintenant

Spécification du produit

  • Encefabol susp. 80,5g/5ml, flask200ml:USD 54.00
  • Encefabol tablets 100mg #50:USD 46.00
  • Somaxon inj. 500mg 2ml #5:USD 46.90
  • Somaxon inj. 1000mg 4ml #5:USD 77.50
  • Ceraxon tablets 500mg #20:USD 188.50

La description

 

Encephabol ® 

Piritinol hydrochloride **0 mg 
Other ingredients: sodium karmelloza ***0, magnesium stearate, colloidal silicon dioxide, sodium carboxymethyl starch, lactose monohydrate, cellulose powder, quinoline yellow *0%, wax mountain glycol, gelatin, gum arabic, wheat flour, titanium oxide (IV), white clay, talc, sucrose. 

Pharmacological properties: encephabol improves the pathologically reduced metabolism in the brain by increasing the capture and utilization of glucose, the exchange of nucleic acids, as well as increased release of acetylcholine at the synapse and the activation of cholinergic neuronal transmission. Encephabol stabilizes cell membranes and improves their function by preventing the formation of free radicals. Encephabol improves the rheological properties of blood: red blood cells increases the elasticity and fluidity of the blood, increases the ATP content in the membrane of red blood cells. In applying encephabol increases blood flow and increased oxygen consumption in ischemic areas of the brain and activates the exchange of glucose in the brain regions that previously defined ischemic damage. Encephabol contributes to the restoration of disturbed metabolic processes in nerve tissue, improve mental performance and improve memory. 
After oral administration, the drug is rapidly absorbed in the digestive tract. Bioavailability averaged *5% (****3%). Time to reach maximum concentration after oral administration of **0 mg encephabol is ****0 minutes. Binding to plasma proteins - ****0%. Rapidly metabolized in the liver with the formation of the main metabolites - *-methyl**-hydroxy**-hydroxymethyl**-methylmercaptomethylperidine and *-methylsulphenilmethylperidine. Conjugated metabolites are primarily in the urine, about 5% - with the feces. The largest part of the dose was excreted within the first 4 hours after ingestion. For day 1 is derived approximately *4% of the dose.The half-life is approximately 2.5 hours penetrates through the BBB, the placental barrier in small amounts - into breast milk. If the kidney function of toxic concentrations in the body are not attained.

Indications: symptomatic treatment of chronic disorders of the brain function in dementia syndromes with the following symptoms: impaired memory and thinking, decreased concentration, fatigue, lack of incentives and motivation, affective disorders. 
Primary degenerative dementia, dementia of vascular origin and mixed forms. Symptomatic treatment of chronic disorders of mental disability. Post-traumatic encephalopathy. Cerebral atherosclerosis. The consequences of encephalitis. Mental retardation, tserebrastenichesky syndrome, encephalopathy in children. 

APPLICATION: dose determined individually, taking into account disease severity and patient response to treatment. The average adult dose is **0 mg - 2 tablets of **0 mg or *0 ml suspension (2 tablespoons). Multiplicity of purposes - 3 times a day. 
Infants and children under 7 years are designated in the form of a suspension: infants, beginning with the third day of life - to 1 ml of suspension in the day in the morning for a month, starting from the 2 nd month of life, this dose is increased by 1 ml of each week until a daily dose until it reaches the 5 ml (1 teaspoon) 1 year old and older, depending on the evidence - 1/**1 teaspoon suspension **3 times a day (from *0 to **0 mg / day) for children aged 7 years and older - **2 teaspoons of suspension **3 times a day (from *0 to **0 mg / day). Children under the age of 7 years of age or older depending on the evidence prescribed **2 tablets **3 times a day (from *0 to **0 mg / day). 
Take medication during or after a meal. Tablets swallowed whole, washed down with fluid.Patients with sleep disorders, as well as children at increased excitability is not recommended to take the medication in the evening. 
Clinical improvement may occur within **4 weeks, but the optimal effect is seen in ***2 weeks.Duration of treatment for chronic diseases must be at least 8 weeks. 
At 3 months, you should verify the presence of indications for further treatment. 

Contraindications: Absolute - Hypersensitivity to piritinol to fructose (for the drug in the form of suspension); relative - a history of kidney disease, expressed by human liver and / or kidney disease; pronounced changes in the composition of peripheral blood acute autoimmune diseases such as systemic lupus erythematosus, myasthenia gravis. 

SIDE EFFECTS: when using the drug for indications and recommended doses, side effects are unlikely. 
Sleep disturbance, at least - irritability, headache, dizziness, fatigue, nausea, vomiting, diarrhea, at least - anorexia, taste disturbances, stomatitis, transient increase of transaminases, cholestasis, allergic reactions of varying severity (skin rash and mucous membranes itching, fever). 

SPECIAL NOTES: in patients with hypersensitivity to D-penicillamine may be allergic reactions, since the latter is similar in chemical structure piritinol (thiol groups). 
Piritinol crosses the placental barrier. The results of the studies did not reveal the presence of the drug teratogenic or embryotoxic action. In breast milk gets a small amount of piritinol. Decision on the possible use of the drug during pregnancy and lactation should be taken after an assessment of risk / benefit ratio. 

INTERACTION: encephabol increases the severity of side effects of penicillamine, gold, drugs, and sulfasalazine. 

OVERDOSE: shows increased symptom severity of side effects. Conduct gastric lavage, activated charcoal designate. 

Storage conditions: at temperatures up to ****5 ° C. Shelf life - 5 years.

Pays: Ukraine
N ° de modèle: Encephabol
Prix FOB: 46 ~ 54 / Box Obtenir le dernier prix
Localité: Donetsk
Prix de commande minimale: 46 per Box
Commande minimale: 5 Box
Packaging Detail: package must not exceed 2kg
Heure de livraison: 2 weeks by post or 2-5 days by EMS/DHL
Capacité de Fournir: 50 Box per Day
Payment Type: D/P, Western Union, Money Gram
Groupe de produits : Nootropic agents

Send a direct inquiry to this supplier

To:

Mr. Yuriy < Pharma Trade >

Je veux savoir: